A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread
Clinical trial NCT03098550 · COMPLETED
Trial details
- NCT number
- NCT03098550
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-15
- Primary completion
- 2020-07-06
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.